Sorafenib is a kinase inhibitor. It’s used to treat advanced renal cell carcinoma, hard-to-operate-on liver cancer, and thyroid cancer that doesn’t respond to iodine therapy. You get it in 200 mg tablets.
You’re supposed to take 400 mg, twice a day – that’s 800 mg in total. And you take them on an empty stomach. The tablets come in bottles with 120 in each.
Sorafenib blocks multiple kinases, including VEGFR, PDGFR, and RAF kinases, and is designed to combat specific cancers by targeting critical pathways involved in tumor growth.
